Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

BACKGROUND: Immune‐checkpoint inhibitors have been shown to improve survival in melanoma patients, but can also trigger immune‐related endocrinopathies, especially hypophysitis and thyroid dysfunction. METHODS: To assess the incidence and the spectrum of endocrinopathies in melanoma patients treated...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Kassi, Eva, Angelousi, Anna, Asonitis, Nikolaos, Diamantopoulos, Panagiotis, Anastasopoulou, Amalia, Papaxoinis, George, Kokkinos, Michalis, Giovanopoulos, Ilias, Kyriakakis, Georgios, Petychaki, Fotini, Savelli, Akrivi, Benopoulou, Olga, Gogas, Helen
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825974/
https://ncbi.nlm.nih.gov/pubmed/31518074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2533
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items